FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops

The U.S. Food and Drug Administration (FDA) has approved Alcon's BRYTLY Redness Reliever Eye Drops, marking the first nonprescription eye drop in the U.S. with apraclonidine to receive such approval. This expands Alcon's over-the-counter portfolio of redness-relief products.